Stocks – GE Soars in Premarket, Newmont Mining, Spring Rise, Kraft Falls

© Reuters. – Stocks in focus in premarket trade Monday:

General Electric (NYSE:) stock rocketed 17.80% by 8:12 AM ET (13:12 GMT) after the company agreed to sell its BioPharma business to Danaher (NYSE:) for $21.4 billion.

• Kraft Heinz (NASDAQ:) stock fell 0.92%, unable to manage even a dead-cat bounce after Friday’s slump after Warren Buffett wrote billions off the value of Berkshire Hathaway (NYSE:)’s stake. While Buffett plans on holding the stake, he will not add to it. Separately, CNBC reported that the company hired Credit Suisse (SIX:) to study strategic options for its Maxwell House coffee business.

• Spark Therapeutics (NASDAQ:) stock surged 120.91% after Roche said it will acquire the company for $114.50 a share, or approximately $4.3 billion.

Newmont Mining (NYSE:) stock rose 1.32% as Barrick Gold offered to acquire the company in an all-stock merger. Barrick’s offer doesn’t envisage any premium for Newmont stock.

• Caesars Entertainment (NASDAQ:) stock advanced 2.43% as the company prepares to offer activist investor Carl Icahn a role in selecting its next chief executive, according to people familiar with the matter cited by Reuters.

• Twitter (NYSE:) stock traded up 0.69% after a company announcement that co-founder and former chief executive Evan Williams (NYSE:) plans to step down from its board of directors at the end of the month.

• Sprint (NYSE:) stock gained 1.40% as the company announced that it would launch commercial 5G beginning in May.

Avon Products (NYSE:) stock jumped 5.30% as the company announced the launch of a new content studio to drive digital growth.

READ  U.S. patent board is unconstitutional, but problem can be fixed - appeals court

• Qualcomm (NASDAQ:) stock rose 1.51% as the company announced a launch of 5G chips for cars, PCS and home broadband in an attempt to move beyond the smartphone market.

Marathon Oil (NYSE:) stock lost 0.83% as the company announced an agreement to sell its assets in the North Sea to RockRose Energy for approximately $140 million.

• Clementia Pharmaceuticals (NASDAQ:) stock soared 71.75% after Ipsen agreed to buy the company in a deal worth approximately $1.31 billion.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



Please enter your comment!
Please enter your name here